5 Therapy and prognostic factors in adult acute lymphoblastic leukaemia
References (92)
- et al.
Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
Blood
(1992) - et al.
Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia
Cancer Genetics and Cytogenetics
(1989) - et al.
High dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy
Blood
(1990) - et al.
Chimeric BCR-abl messenger RNA as a marker for minimal residual disease in patients transplanted for Philadelphia chromosome-positive lymphoblastic leukemia
Blood
(1991) - et al.
Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy
Blood
(1989) - et al.
Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia
Blood
(1988) - et al.
Adult acute lymphoblastic leukemia. Response to therapy according to presenting features in 62 patients
European Journal of Cancer and Clinical Oncology
(1982) - et al.
Philadelphia chromosome positive acute lymphoblastic leukemia
Hematology and Oncology Clinics of North America
(1993) - et al.
Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report
Blood
(1991) - et al.
Improved results of an intensified therapy in adult acute lymphocytic leukemia
Annals of Oncology
(1991)
Multidrug resistance (mdr-1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity
Blood
(1991)
Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction
Lancet
(1991)
Expression of the mdr-1/P-170 gene in patients with acute lymphoblastic leukemia
Blood
(1989)
Chemotherapy of adult acute lymphoblastic leukaemia
Baillière's Clinical Haematology
(1991)
Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B study (8762)
Blood
(1992)
Detection of BCR/ABL translocation by polymerase chain reaction in leukemia progenitor cells (ALL-CFU) from patients with acute lymphoblastic leukemia (ALL)
Experimental Hematology
(1992)
Short course high dose mitoxantrone with high dose cytarabine is effective therapy for adult lymphoblastic leukemia
Leukemia
(1991)
E-rosette positive acute lymphoblastic leukemia in adolescents and adults
British Journal of Haematology
(1983)
Remission induction of meningeal leukemia with high-dose intravenous methotrexate
Journal of Clinical Oncology
(1985)
Treatment of acute lymphoblastic leukemia in adults
British Journal of Haematology
(1986)
HLA-identical sibling bone marrow transplants for Ph1-chromosome positive acute lymphoblastic leukemia in first remission
Experimental Hematology
(1991)
Treatment of adult acute lymphoblastic leukaemia (ALL) over a 16 year period
Leukemia
(1992)
Therapy of adult acute lymphocytic leukemia (ALL)
Haematologica
(1991)
Prognostic value of immunologic markers in adults with acute lymphoblastic leukemia
New England Journal of Medicine
(1978)
A randomised, controlled, multicenter trial of recombinant human granulocyte colony stimulating factor (Filgrastim) in patients treated by bone marrow transplantation (BMT) with total body irradiation (TBI) for acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL)
Blood
(1992)
Central nervous system leukemia
Prognostic significance of the Philadelphia chromosome in adult acute lymphoblastic leukemia
Bone marrow transplantation for acute lymphoblastic leukemia
Minimal residual disease in acute lymphoblastic leukemia detected by immune selection and gene rearrangement analysis
Journal of Clinical Oncology
(1989)
Bone marrow transplatation (BMT) for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph1 + ALL)
Purging of multiple drug resistant acute lymphoblastic leukemia (L100) for autologous bone marrow transplantation with vincristine (V) and VP-16 (VP): selective modulation by verapamil (VPL)
GM-CSF in childhood acute lymphoblastic leukemia: randomized double blind trial during intensification phase
Blood
(1992)
Critical analysis of detecting minimal residual leukemia
High-dose cytarabine therapy in adult acute lymphocytic leukemia
Adult acute lymphoblastic leukemia: the Eastern Cooperative Oncology Group experience
Leukemia
(1992)
Acute lymphoblastic leukemia in adults
Importance of long-term follow-up in evaluating treatment regimens for adults with acute lymphoblastic leukemia
Haematology and Blood Transfusion
(1990)
Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB study
Leukemia
(1991)
Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia
Leukemia
(1991)
The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B
Journal of Clinical Oncology
(1991)
Intensive treatment of acute lymphatic leukaemia in adults: ALL86 protocol
Haematologica
(1991)
Burkitt cell acute leukaemia (L3 ALL) in adults: a report of 18 cases
British Journal of Haematology
(1989)
Treatment of 218 adult acute lymphoblastic leukemias
Characteristics and therapeutic results of 48 adult Philadelphia positive (Ph 1) acute lymphoblastic leukemias (ALL)
Blood
(1990)
Adult acute lymphoblastic leukemia (ALL). First interim analysis of the evolution of 467 patients (French Multicentric Trial LALA 87)
Haematologica
(1991)
Prognostic significance of myeloid-associated antigen expression on blast cells in children with acute lymphoblastic leukemia (ALL)
Onkologie
(1991)
Cited by (23)
Adult acute lymphoblastic leukaemia
2004, Critical Reviews in Oncology/HematologyBcr-Abl variants: Biological and clinical aspects
2002, Leukemia ResearchImmunophenotypic analysis of acute lymphocytic leukemia
2002, Hematology/Oncology Clinics of North AmericaUnrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: Strong graft-versus-leukemia effect and risk factors determining outcome
2001, BloodCitation Excerpt :Long-term disease-free survival (DFS) for adult acute lymphoblastic leukemia (ALL) has only moderately improved during the last 2 decades despite more intensive induction and postinduction therapy and better supportive care facilities.1-3
Treatment of acute leukemia
1999, Annals of OncologyLevels of expression of CAF7 (CD98) have prognostic significance in adult acute leukemia
1998, Leukemia Research
Copyright © 1994 Published by Elsevier Ltd.